Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

Consumer Reports warns that there are important considerations, especially for older adults, before starting these treatments.

Weight loss medications like Wegovy and Zepbound are gaining popularity as millions turn to them for quick results and ...

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...

A judge is set to hear arguments about whether to honor the Department of Justice's request that corruption charges against ...

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, clinical trial experts and doctors say they may also need to demonstrate ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Discover how GLP-1 weight loss medications like Ozempic and Wegovy are linked to reduced risks of dementia heart disease and more—alongside potential side effects to consider ...

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion. The drugmaker ...